Category: Uncategorized

Sun Pharmaceutical’s updated label for Unloxcyt receives US FDA approval

01/12/2025 Published by vivi

The U.S. Food and Drug Administration (USFDA) has approved an updated label for Unloxcyt (cosibelimab-ipdl) for the treatment of adults... Read more

Tags: #Global Trends

Generic Drug Approval Secured for Type 2 Diabetes Treatment in the US

01/12/2025 Published by vivi

A pharmaceutical company has announced that it secured tentative approval from the United States Food and Drug Administration (USFDA) for... Read more

Category: Uncategorized

Tags: #Global Trends

Major Pharmaceutical Group Acquires Preclinical Cancer Asset

01/12/2025 Published by vivi

In light of substantial recent investments in oncology and mounting competition, a leading pharmaceutical corporation is seeking a new approach... Read more

Category: Uncategorized

Tags: #Global Trends

Novel Immunotherapy Regimen Approved for Early-Stage Gastric Cancer

01/12/2025 Published by vivi

The U.S. Food and Drug Administration (FDA) has granted approval for the use of Durvalumab (an immunotherapy) in combination with... Read more

Category: Uncategorized

Tags: #Global Trends

Expedited Review Sought for New Higher-Dose Obesity Treatment

01/12/2025 Published by vivi

A pharmaceutical corporation has submitted a supplemental application for a higher dose semaglutide injectable (7.2 mg) to the U.S. Food... Read more

Category: Uncategorized

Tags: #Global Trends

Global Strategic Restructuring: A Major Pharma Group’s Shift Toward Automation and Production Reallocation

01/12/2025 Published by vivi

The recent decisions by a leading Swiss pharmaceutical group highlight a broader trend within the industry: prioritizing automation, advanced manufacturing... Read more

Category: Uncategorized

Tags: #Global Trends